CV19 Vaccine Study Halted Over ‘Adverse Reaction’
September 9, 2020 |By
Getty Cells containing the novel coronavirus SARS-CoV-2 are seen through a microscope at the Stabilitech laboratory in Burgess Hill south east England, on May 15, 2020 where scientists are trying to develop an oral vaccine for the COVID-19 illness.
“Trials for a potential coronavirus vaccine, which is being tested at dozens of U.S. sites, have been put on pause after a participant developed an adverse reaction, STAT News said.
AstraZeneca, in partnership with the University of Oxford, has halted its Phase 3 trials of a vaccine after a “standard review process” found a “potentially unexplained illness in one of the trials,” according to a statement obtained by the outlet on September 8.
The participant is located in the United Kingdom, STAT indicated.
AstraZeneca initiated its Phase 3 trial in the United States on August 31, according to an online news release.
Here’s the full statement $azn sent us for this story: https://t.co/kmjVIHGY1Tpic.twitter.com/DNadhv0KbD
— Rebecca Robbins (@RebeccaDRobbins) September 8, 2020
Although AstraZeneca did not disclose any details surrounding the participant or their adverse reaction, it indicated that it is “working to expedite the review of the single event to minimize any potential impact on the trial timeline,” according to STAT News.”